In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats

European Journal of Pharmaceutical Sciences

Volumn 18, Issue 2, 2003, Pages 141-147

  Bian, Shengjie ^a,b   Doh, Hea Jeong ^a   Zheng, Junmin ^b   Kim, Jung Sun ^c   Lee, Chi Ho ^a   Kim, Dae Duk ^a  

^a Pusan National University   (South Korea)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c Dongseo University   (South Korea)

Author keywords

Formulation; Gentisic acid; Patches; Permeation; Skin Deposition; Topical delivery

Indexed keywords

ADHESIVES; DEPOSITION; DERMATOLOGY; ENZYMES; SYNTHESIS (CHEMICAL);

SKIN PERMEATION;

ORGANIC ACIDS;

DIETHYLENE GLYCOL MONOETHYL ETHER; DODECYLAMINE; GENTISIC ACID; LAUROCAPRAM; MELANIN; MONOPHENOL MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG POTENCY; ENZYME INHIBITION; ENZYME SYNTHESIS; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN DISEASE; SKIN PERMEABILITY;

ADMINISTRATION, TOPICAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; GENTISATES; HYDROXYBENZOIC ACIDS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION;

EID: 0037314973     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(02)00255-5     Document Type: Article

References (25)

1. Alberti I., Kalia Y.N., Bonny J.D., Guy R.H. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J. Control. Release. 71:(3):2001;319-327.
2. Arima H., Miyaji T., Irie T., Hirayama F., Uekama K. Enhancing effect of hydroxypropyl-β-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin. Eur. J. Pharm. Sci. 6:1998;53-59.
3. Arraudeau, J., Aubert, L., 1998. Use of benzoic acid derivatives to stimulate the process of epidermal renewal. US patent 5,766,613.
4. Aungst B.J., Blake J.A., Hussain M.A. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7:1990;712-718.
5. Bolognia J.L., Sodi S.A., Osber M.P., Pawelek J.M. Enhancement of the depigmentary effect of hydroquinone by cystamine and butionine sulfoximine. Br. J. Dermatol. 133:1995;349-357.
6. Cabanes J., Chazarra S., Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is the low-binding inhibition of catecholase activity of tyrosinase. J. Pharm. Pharmacol. 46:1994;982-985.
7. Cooper E.R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 73:1984;1153-1156.
8. Curto E.V., Kwong C., Hermersdorfer H., Glatt H., Santis C., Virador V., Hearing J.V., Dooley T.P. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem. Pharmacol. 57:1999;663-672.
9. Francoeur M.L., Golden G.M., Potts R.O. Oleic acid: its effects on stratum corneum in relation to (trans)dermal drug delivery. Pharm. Res. 7:1990;621-627.
10. Funke A.P., Schiller R., Motzkus H.W., Gunther C., Muller R.H., Lipp R. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations. Pharm. Res. 19:2002;661-668.
11. Jimbow K., Fitzpatrick T.B., Wick M.M. Biochemistry and physiology of melanin pigmentation. Goldsmith L.A. Physiology, Biochemistry and Molecular Biology of the Skin. 1991;873-909 Oxford University Press, Oxford.
12. Maeda K., Fukuda M. Arbutin: mechanism of its depigmentation action in human melanocyte culture. J. Pharmacol. Exp. Ther. 276:1996;765-769.
13. Minghetti P., Casiraghi A., Cilurzo F., Montanari L. Development of local patches containing melilot extract and ex vivo-in vivo evaluation of skin permeation. Eur. J. Pharm. Sci. 10:2000;111-117.
14. Nakayama H., Ebihara T., Satoh N., Jinnai T. Depigmentation agents. Elsner P., Maibach H.I. Cosmeceuticals. 2000;123-144 Marcel Dekker, New York.
15. Ogiso T., Shintani M. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J. Pharm. Sci. 79:1990;1065-1071.
16. Qvist M.H., Hoeck U., Kreilgaard B., Madsen F., Frokjaer S. Release of chemical permeation enhancers from drug-in-adhesive transdermal patches. Int. J. Pharm. 231:2002;253-263.
17. Reifenrath W.G., Robinson P.B., Bolton V.D., Aliff R.E. Percutaneous penetration of mosquito repellents in the hairless dog: effect of dose on percentage penetration. Food Cosmet. Toxicol. 19:1981;195-199.
18. Schved F., Kahn V. Effect of different isomers of dihydroxybenzoic acids (DBA) on the rate of DL-dopa oxidation by mushroom tyrosinase. Pig. Cell Res. 5:(2):1992;58-64.
19. Surber C., Smith E.W., Schwarb F.P., Maibach H.I. Drug concentration in the skin. Bronaugh R.L., Maibach H.I. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methodology. 1999;347-374 Marcel Dekker, New York.
20. Takashima H., Nomura H., Imai Y., Mima H. Ascorbic acid esters and skin pigmentation. Am. Perf. Cosmetol. 86:1971;29-36.
21. Tanojo H., Bouwstra J.A., Junginger H.E., Bodde H.E. In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies. Pharm. Res. 14:(1):1997;42-49.
22. Tojo K. The prediction of transdermal permeation: mathematical models. Ghosh T.K., Pfister W.R., Yum S.I. Transdermal and Topical Drug Delivery Systems. 1997;113-138 Interpharm Press, Buffalo Grove, IL.
23. Valjakka-Koskela R., Hirvonen J., Monkkonen J., Kiesvaara J., Antila S., Lehtonen L., Urtti A. Transdermal delivery of levosimendan. Eur. J. Pharm. Sci. 11:(4):2000;343-350.
24. Wedig J.H., Feldmann R.J., Maibach H.I. Percutaneous penetration of the magnesium sulfate adduct of dipyrithione in man. Toxicol. Appl. Pharmacol. 41:1977;1-6.
25. Williams A.C., Bary B.W. Skin absorption enhancers. Crit. Rev. Ther. Drug. 9:1992;305-353.